Rich Pharmaceuticals (RCHA) 8-K Changes in Registrant's Certifying Accountant

 

September 14, 2017

Securities and Exchange Commission

450 Fifth Street N.W.

Washington, DC 20549

We have read the statements of Rich Pharmaceuticals, Inc., pertaining to our firm included under Item 4.01 of Form 8-K dated September 5, 2017 and agree with such statements as they pertain to our firm.

Sincerely,

/s/ KLJ & Associates, LLP